Announcements and press

Releases

• 2026-06-26

  Regulatory

  PhAST receives FDA 510(k) clearance for the PhAST BC GN Panel

  The panel provides phenotypic antimicrobial susceptibility results for Gram-negative pathogens for 15 antimicrobials directly from positive blood cultures.

  FDA 510(k) summary, K253316 ↗(opens in a new tab)